A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection-Reference-Cited by-同舟云学术

A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection

Published:2015-05 Issue:5 Volume:13 Page:1017-1024
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Chang Kuo-Chin,Tseng Po-Lin,Wu Yi-Ying,Hung Hung-Chao,Huang Chao-Min,Lu Sheng-Nan,Wang Jing-Houng,Lee Chuan-Mo,Chen Chien-Hung,Tsai Ming-Chao,Yen Yi-Hao,Lin Ming-Tsung,Wu Cheng-Kun,Huang Chao-Cheng,Chen Hsiu-Hsi,Hu Tsung-Hui

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference34 articles.

1. Disease progression in chronic hepatitis C: modifiable and non-modifiable factors;Missiha;Gastroenterology,2008

2. EASL Clinical Practice Guidelines: management of hepatitis C virus infection;J Hepatol,2011

3. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C;Tanaka;Nat Genet,2009

4. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy;Suppiah;Nat Genet,2009

5. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance;Ge;Nature,2009

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact;Hepatobiliary Surgery and Nutrition;2024-08

2. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication;Clinical and Molecular Hepatology;2024-07-01

3. Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong;BMC Gastroenterology;2024-01-25

4. Low-Cost Predictors for Liver Function and Clinical Outcomes after Sustained Virological Response in Patients with HCV-Related Cirrhosis and Thrombocytopenia;Medicina;2023-01-11

5. Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes;Egyptian Journal of Medical Human Genetics;2022-02-16